Stocks · Health care · Surgical & Medical Instruments & Apparatus

TriSalus Life Sciences, Inc.

TLSI Clue Score59
United States Fiscal year ends December CIK 0001826667 Results filed 6 Aug 2026

What the insiders did No buying or selling

By person

18 insiders · 0 transactions
7.8×

Mary Szela holds 7.8 times base salary in stock. $4.72M of shares against $600.92K in salary for 2025.

Salary from the company's own proxy. The shares are what Mary Szela last reported holding, valued at $4.39, the price Common Stock was last bought or sold at on the open market here, on 5 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Equity AB Frankenius
10% owner
—
—
—
6,989,748
$30.68M
+13.3%
Michael P Stansky
Director
—
—
—
1,640,420
$7.20M
+162.2%
David J Matlin
Director
—
—
—
1,323,210
$5.81M
+42.0%
Mary T Szela
CEO and President
—
—
—
1,074,990
$4.72M
+107.5%
Kerry R Hicks
Director
—
—
—
542,790
$2.38M
+5.5%
Sean Murphy
Director
—
—
—
321,721
$1.41M
+47.2%
David Patience
Chief Financial Officer
—
—
—
261,107
$1.15M
—
Arjun JJ Desai
Director
—
—
—
247,127
$1.08M
−10.8%
Bryan F. Cox
Chief of Research
—
—
—
162,805
$714.71K
+74.6%
Mats Wahlstrom
Director
—
—
—
147,555
$647.77K
—
Richard Marshak
Chief Commercial Officer
—
—
—
127,994
$561.89K
+328.0%
Jennifer Stevens
Chief Regulatory Officer
—
—
—
123,794
$543.46K
+277.6%
Jodi Devlin
Chief of Clinical Operations
—
—
—
97,364
$427.43K
+536.1%
Richard Henry Marshall
Chief Medical Officer
—
—
—
90,000
$395.10K
+200.0%
William Valle
Director
—
—
—
83,241
$365.43K
—
James Emmett Young
Chief Financial Officer
—
—
—
79,663
$349.72K
+763.5%
Gary B. Gordon
Director
—
—
—
72,510
$318.32K
—
Liselotte Hyveled
Director
—
—
—
10,040
$44.08K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.